Lessening of neuroinflammation by targeted deletion of astroglial cFLIP, or cFLIPL, provided RGC protection in ocular hypertensive eyes, supporting the potential for immunomodulation in glaucoma treatment. The gene discussed is CFLAR; the disease is glaucoma.